M
Muriel Rabilloud
Researcher at University of Lyon
Publications - 244
Citations - 6471
Muriel Rabilloud is an academic researcher from University of Lyon. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 38, co-authored 217 publications receiving 5329 citations. Previous affiliations of Muriel Rabilloud include Lyon College & Claude Bernard University Lyon 1.
Papers
More filters
Journal ArticleDOI
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Olivier Rouvière,Philippe Puech,Raphaële Renard-Penna,Michel Claudon,Catherine Roy,Florence Mège-Lechevallier,Myriam Decaussin-Petrucci,Marine Dubreuil-Chambardel,Laurent Magaud,Laurent Remontet,Laurent Remontet,Alain Ruffion,Marc Colombel,Sebastien Crouzet,Anne-Marie Schott,Laurent Lemaitre,Muriel Rabilloud,Muriel Rabilloud,Nicolas Grenier,Nicolas Barry Delongchamps,Romain Boutier,Flavie Bratan,S. Brunelle,Philippe Camparo,Pierre Colin,Jean-Michel Correas,François Cornelis,François Cornud,Fanny Cros,Jean-Luc Descotes,Pascal Eschwege,Gaelle Fiard,Jean-Philippe Fendler,Hocine Habchi,Philippe Hallouin,Ahmed Khairoune,Hervé Lang,Y. Lebras,F Lefèvre,Bernard Malavaud,Paul C. Moldovan,Nicolas Mottet,Pierre Mozer,Pierre Nevoux,G. Pagnoux,Gilles Pasticier,Daniel Portalez,E. Potiron,Athivada Soto Thammavong,Marc-Olivier Timsit,Arnault Viller,Jochen Walz +51 more
TL;DR: Obtaining a multiparametric MRI before biopsy in biopsy-naive patients can improve the detection of clinically significant prostate cancer but does not seem to avoid the need for systematic biopsy.
Journal ArticleDOI
Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Francois-Joseph Murat,Laura Poissonnier,Muriel Rabilloud,Aurélien Belot,Raymonde Bouvier,Olivier Rouvière,Jean-Yves Chapelon,Albert Gelet +7 more
TL;DR: Salvage HIFU is a curative treatment option for local relapse after EBRT with acceptable morbidity and careful patient selection is imperative depending upon the prognostic factors.
Journal ArticleDOI
Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.
Gaetan Lesca,Carla Olivieri,Nelly Burnichon,Fabio Pagella,Marie-France Carette,Brigitte Gilbert-Dussardier,Cyril Goizet,Joelle Roume,Muriel Rabilloud,Jean-Christophe Saurin,Vincent Cottin,Jérôme Honnorat,Florence Coulet,Sophie Giraud,Alain Calender,Cesare Danesino,Elisabetta Buscarini,Henri Plauchu +17 more
TL;DR: This study shows major differences between HHT1 and HHT2 phenotypes, which should be taken into account for future clinical studies.
Journal ArticleDOI
Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?
N. Girouin,Florence Mège-Lechevallier,Alejandro Tonina Senes,Alvine Bissery,Muriel Rabilloud,J.-M. Marechal,Marc Colombel,Denis Lyonnet,Denis Lyonnet,Olivier Rouvière,Olivier Rouvière +10 more
TL;DR: DCE-MRI using pelvic phased-array coils and simple visual diagnostic criteria is more sensitive for tumor localization than T2-weighted imaging.
Journal ArticleDOI
Predicting Visual Outcome After Treatment of Pituitary Adenomas With Optical Coherence Tomography
Maud Jacob,Gérald Raverot,Gérald Raverot,Emmanuel Jouanneau,Emmanuel Jouanneau,Françoise Borson-Chazot,Françoise Borson-Chazot,Gilles Perrin,Muriel Rabilloud,Muriel Rabilloud,Caroline Tilikete,Caroline Tilikete,Martine Bernard,Alain Vighetto,Alain Vighetto +14 more
TL;DR: RNFL thinning measured by OCT puts the patient at decreased chance of recovery of an initial VF defect three months after treatment in pituitary adenomas compressing the anterior visual pathways.